QingSong Health (HKSE:02661) EBIT: HK$81 Mil (TTM As of Dec. 2025)


HKSE:02661 QingSong Health Corp HKSE:02661
18 GF Score
Price HK$8.38
! 2 Warning Signs
View Full Analysis

What is QingSong Health EBIT?

QingSong Health HKSE:02661 -7.40% 18 EBIT is HK$81 Mil as of Dec. 2025. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

QingSong Health's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$35 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$81 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. QingSong Health's annualized ROC % for the quarter that ended in Dec. 2025 was 7.32%. QingSong Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 988.78%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. QingSong Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 10.81%.

QingSong Health  (HKSE:02661) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

QingSong Health's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=70.228 * ( 1 - 0% )/( (1837.735 + 80.09)/ 2 )
=70.228/958.9125
=7.32 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=695.866 - 124.534 - ( 446.97 - max(0, 1922.529 - 656.126+446.97))
=1837.735

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1316.776 - 179.383 - ( 1057.303 - max(0, 201.615 - 1282.13+1057.303))
=80.09

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

QingSong Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=70.228/( ( (7.937 + max(-1749.774, 0)) + (6.268 + max(-11.96, 0)) )/ 2 )
=70.228/( ( 7.937 + 6.268 )/ 2 )
=70.228/7.1025
=988.78 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(89.581 + 0 + 79.061) - (124.534 + 0 + 1793.882)
=-1749.774

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(97.333 + 0 + 88.59) - (179.383 + 0 + 18.5)
=-11.96

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

QingSong Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=81.003/749.213
=10.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QingSong Health EBIT Related Terms

QingSong Health EBIT Historical Data

* Premium members only.

The historical data trend for QingSong Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QingSong Health EBIT Chart

QingSong Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBIT
163.87 156.40 63.55 81.49

QingSong Health Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial 0.00 39.95 23.92 45.89 35.11

HKSE:02661 vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, QingSong Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QingSong Health EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, QingSong Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where QingSong Health's EV-to-EBIT falls into.


HKSE:02661
18GF Score
QingSong Health Corp HKSE:02661
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QingSong Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$81 Mil mean?
QingSong Health (HKSE:02661) has a EBIT of HK$81 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on QingSong Health.
Is QingSong Health's EBIT too high?
QingSong Health's current EBIT is HK$81 Mil. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's EBIT compare to VEEV and BTSG?
QingSong Health's EBIT of HK$81 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on QingSong Health. QingSong Health's current EBIT is HK$81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current EBIT of HK$81 Mil. The current EBIT is HK$81 Mil. QingSong Health's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current EBIT is HK$81 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QingSong Health Business Description

Address No. 28 Andingmen East Street, 7th floor, Building F, Yonghe Mansion, Dongcheng District, Beijing, CHN
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score

Get the complete analysis for HKSE:02661

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$8.38
Price